See all treatments in the PatientsLikeMe system shared by patients just like you.
Generic Name: 4-Aminopyridine (4-AP)
What is Fampridine-SR? Fampridine-SR, a sustained release formulation of 4-Aminopyridine, blocks potassium channels and prolongs action potentials thereby increasing transmitter release at the neuromuscular junction and elsewhere. It has been under study for spinal cord injuries and for Multiple Sclerosis.
9 patients in the community are taking or have taken Fampridine-SR.
| Reason | # Patients | Percentage of patients |
|---|---|---|
| Other | 5 | 55% |
| Mobility | 2 | 22% |
| disease-related symptoms | 1 | 11% |
| Stiffness/spasticity | 1 | 11% |
How long current patients have been taking Fampridine-SR or how long patients were taking Fampridine-SR before stopping.
| 0-1 month | 1-3 months | 3-6 months | 6 months-1year | 1-2 years | 2 years or more |
|---|---|---|---|---|---|
|
0
|
0
|
0
|
0
|
0
|
| Reason | # Patients | Percentage of patients | |
|---|---|---|---|
| Other | 1 | 100% |
Results from 2 patient evaluations. See the overall results and all individual evaluations.
| Major | 50% | 3 |
|---|---|---|
| Moderate | 50% | 3 |
Other
| Severe | 8% | 1 |
|---|---|---|
| Moderate | 8% | 1 |
| Mild | 8% | 1 |
| None | 77% | 10 |
Summary results are based on 2 individual responses. For more information, see overall results for Adherence, Burden and Cost.